Package 0228-3062-11

Brand: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate

Generic: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 0228-3062-11
Digits Only 0228306211
Product NDC 0228-3062
Product ID 0228-3062_75c254af-0db3-4c40-83ad-f308be628dde
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3062-11)

Marketing

Marketing Status
Marketed Since 2012-06-22
Brand dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
Generic dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "75c254af-0db3-4c40-83ad-f308be628dde", "openfda": {"upc": ["0302283059110", "0302283064114", "0302283063117"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_set_id": ["c5c2d060-452c-4f76-ad93-2e41fd8f06c2"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3062-11)", "package_ndc": "0228-3062-11", "marketing_start_date": "20120622"}], "brand_name": "Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate", "product_id": "0228-3062_75c254af-0db3-4c40-83ad-f308be628dde", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0228-3062", "dea_schedule": "CII", "generic_name": "Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "1.25 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "1.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "1.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "1.25 mg/1"}], "application_number": "ANDA077302", "marketing_category": "ANDA", "marketing_start_date": "20120622", "listing_expiration_date": "20271231"}